The Journal of Immunology, Vol 137, Issue 11 3475-3483, Copyright © 1986 by American Association of Immunologists

ARTICLES

Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis

J Muller-Quernheim, C Saltini, P Sondermeyer and RG Crystal

Sarcoidosis is a systemic disorder characterized by the accumulation of large numbers of interleukin 2 (IL 2) releasing helper (Leu-3+) T cells in involved organs. To determine whether the IL 2 gene is activated in sarcoidosis T cells in a systemic manner or only at sites of disease, cells obtained by bronchoalveolar lavage of individuals with active sarcoidosis, inactive sarcoidosis, and normals were evaluated for the spontaneous presence of IL 2 transcripts by using a human IL 2 cDNA probe and Northern analysis of extracted RNA. Freshly recovered lung cells of individuals with active pulmonary sarcoidosis contained 0.85 kilobase pairs (kb) IL 2 mRNA transcripts. In contrast, no IL 2 mRNA transcripts could be detected in fresh autologous blood T cells or in purified autologous blood Leu-3+ T cells, although IL 2 mRNA transcripts were inducible in these cells by phytohemaglutinin/phorbol myristic acetate. The sarcoid lung T cells, however, did not express the IL 2 gene constitutively; when placed in culture with no stimulation and evaluated after 24 hr, they demonstrated down regulation of the amounts of IL 2 mRNA transcripts, despite the fact that they were capable of re-expressing the IL 2 gene and releasing more IL 2 in response to added activation signals. Thus the activation of the IL 2 gene in T cells in active sarcoidosis occurs at the sites of disease and is not a generalized property of T cells throughout the body, and is not sustained if the T cells are removed from the sites of disease. Although the cause of sarcoid is unknown, these observations are consistent with the concept that sarcoid is associated with local stimuli at the site of disease eliciting the Leu-3+ T cell IL 2 gene activation that plays such a critical role in the pathogenesis of this disease.

This article has been cited by other articles:

				M. M. Zeigler, A. I. Doseff, M. F. Galloway, J. M. Opalek, P. T. Nowicki, J. L. Zweier, C. K. Sen, and C. B. Marsh Presentation of Nitric Oxide Regulates Monocyte Survival through Effects on Caspase-9 and Caspase-3 Activation J. Biol. Chem., April 4, 2003; 278(15): 12894 - 12902. [Abstract] [Full Text] [PDF]

				H. Fehrenbach, G. Zissel, T. Goldmann, T. Tschernig, E. Vollmer, R. Pabst, and J. Muller-Quernheim Alveolar macrophages are the main source for tumour necrosis factor-{alpha} in patients with sarcoidosis Eur. Respir. J., March 1, 2003; 21(3): 421 - 428. [Abstract] [Full Text] [PDF]

				J Grunewald, J Wahlstrom, M Berlin, H Wigzell, A Eklund, and O Olerup Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DR{beta} chain conformation Thorax, April 1, 2002; 57(4): 348 - 352. [Abstract] [Full Text] [PDF]

				M. Conron, J. Bondeson, P. Pantelidis, H. L. C. Beynon, M. Feldmann, R. M. duBois, and B. M. J. Foxwell Alveolar Macrophages and T Cells from Sarcoid, but Not Normal Lung, Are Permissive to Adenovirus Infection and Allow Analysis of NF-kappa B-Dependent Signaling Pathways Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 141 - 149. [Abstract] [Full Text] [PDF]

				U. Costabel Sarcoidosis: clinical update Eur. Respir. J., July 1, 2001; 18(32_suppl): 56S - 68s. [Abstract] [Full Text] [PDF]

				M Möllers, S P Aries, D Drömann, B Mascher, J Braun, and K Dalhoff Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis Thorax, June 1, 2001; 56(6): 487 - 493. [Abstract] [Full Text]

				T. Koura, Y. Gon, S. Hashimoto, A. Azuma, S. Kudoh, Y. Fukuda, I. Sugawara, J. Yodoi, and T. Horie Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation Thorax, September 1, 2000; 55(9): 755 - 761. [Abstract] [Full Text]

				M. Conron, C. Young, and H. L. C. Beynon Calcium metabolism in sarcoidosis and its clinical implications Rheumatology, July 1, 2000; 39(7): 707 - 713. [Abstract] [Full Text] [PDF]

				J. GRUNEWALD, M. BERLIN, O. OLERUP, and A. EKLUND Lung T-Helper Cells Expressing T-cell Receptor AV2S3 Associate with Clinical Features of Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 814 - 818. [Abstract] [Full Text] [PDF]

				E. RICHTER, Y. P. KATARIA, G. ZISSEL, J. HOMOLKA, M. SCHLAAK, and J. MÜLLER-QUERNHEIM Analysis of the Kveim-Siltzbach Test Reagent for Bacterial DNA Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1981 - 1984. [Abstract] [Full Text]

				J Wahlström, M Berlin, C M Sköld, H Wigzell, A Eklund, and J Grunewald Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis Thorax, April 1, 1999; 54(4): 339 - 346. [Abstract] [Full Text]

				M. W. ZIEGENHAGEN, U. K. BENNER, G. ZISSEL, P. ZABEL, M. SCHLAAK, and J. MÜLLER-QUERNHEIM Sarcoidosis: TNF-alpha Release from Alveolar Macrophages and Serum Level of sIL-2R Are Prognostic Markers Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1586 - 1592. [Abstract] [Full Text]

				G. ZISSEL, I. BÄUMER, B. FLEISCHER, M. SCHLAAK, and J. MÜLLER-QUERNHEIM TCR Vbeta Families in T Cell Clones from Sarcoid Lung Parenchyma, BAL, and Blood Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1593 - 1600. [Abstract] [Full Text]